Moody Aldrich Partners LLC Ventyx Biosciences, Inc. Transaction History

Moody Aldrich Partners LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	BUY	$29.8 - $40.3 $44,431 - $60,087	1,491 Added 4.09%	37,988 $1.32 Million
Q2 2023 Jul 28, 2023	SELL	$28.53 - $39.55 $1,512 - $2,096	-53 Reduced 0.15%	36,497 $1.2 Million
Q1 2023 Apr 27, 2023	SELL	$29.51 - $46.65 $1.26 Million - $1.99 Million	-42,700 Reduced 53.88%	36,550 $1.22 Million
Q4 2022 Jan 23, 2023	BUY	$24.16 - $36.38 $1.91 Million - $2.88 Million	79,250 New	79,250 $0

125

52.9M

35.3K

83K

Ticker VTYX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,527,200
Market Cap $116M
Description
Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...

Get notified when there are updates to the investment portfolio of Moody Aldrich Partners LLC, based on Form 13F filings with the SEC.

Stay updated on Moody Aldrich Partners LLC with notifications on news.